• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600

    3/26/24 6:22:00 PM ET
    $PGTI
    $ROIV
    $RUN
    $SPGI
    Building Products
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $PGTI alert in real time by email

    NEW YORK, March 26, 2024 /PRNewswire/ -- Roivant Sciences Ltd (NASD:ROIV) will replace Sunrun Inc. (NASD:RUN) in the S&P MidCap 400, and Sunrun will replace PGT Innovations Inc. (NYSE:PGTI) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, April 1. MITER Brands is acquiring PGT Innovations in a transaction expected to be completed on or about March 28 pending final conditions.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    April 1, 2024

    S&P MidCap 400

    Addition

    Roivant Sciences

    ROIV

    Health Care



    S&P MidCap 400

    Deletion

    Sunrun

    RUN

    Industrials



    S&P SmallCap 600

    Addition

    Sunrun

    RUN

    Industrials



    S&P SmallCap 600

    Deletion

    PGT Innovations

    PGTI

    Industrials

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected]

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/roivant-sciences-set-to-join-sp-midcap-400-sunrun-to-join-sp-smallcap-600-302100281.html

    SOURCE S&P Dow Jones Indices

    Get the next $PGTI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PGTI
    $ROIV
    $RUN
    $SPGI

    CompanyDatePrice TargetRatingAnalyst
    S&P Global Inc.
    $SPGI
    10/1/2025$540.00Buy
    Seaport Research Partners
    Sunrun Inc.
    $RUN
    10/1/2025$21.00Hold → Buy
    Jefferies
    Roivant Sciences Ltd.
    $ROIV
    9/2/2025$16.00Buy
    Citigroup
    Sunrun Inc.
    $RUN
    8/18/2025$16.00Sector Perform → Outperform
    RBC Capital Mkts
    Sunrun Inc.
    $RUN
    8/7/2025$13.00 → $14.00Buy
    TD Cowen
    Roivant Sciences Ltd.
    $ROIV
    7/10/2025$19.00Buy
    Goldman
    Sunrun Inc.
    $RUN
    7/9/2025$11.00Underperform → Hold
    Jefferies
    Sunrun Inc.
    $RUN
    7/8/2025Underweight → Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $PGTI
    $ROIV
    $RUN
    $SPGI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO Pulik Richard covered exercise/tax liability with 2,341 shares, decreasing direct ownership by 0.60% to 389,508 units (SEC Form 4)

    4 - Roivant Sciences Ltd. (0001635088) (Issuer)

    9/30/25 9:00:25 PM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CFO Pulik Richard covered exercise/tax liability with 2,129 shares, decreasing direct ownership by 0.54% to 391,849 units (SEC Form 4)

    4 - Roivant Sciences Ltd. (0001635088) (Issuer)

    9/23/25 9:00:27 PM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & Immunovant CEO Venker Eric exercised 1,562,374 shares at a strike of $3.85 and sold $25,524,777 worth of shares (1,711,000 units at $14.92), decreasing direct ownership by 9% to 1,504,959 units (SEC Form 4)

    4 - Roivant Sciences Ltd. (0001635088) (Issuer)

    9/23/25 9:00:20 PM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PGTI
    $ROIV
    $RUN
    $SPGI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    S&P Global Schedules Third Quarter 2025 Earnings Announcement and Conference Call for Thursday, October 30, 2025

    NEW YORK, Oct. 2, 2025 /PRNewswire/ -- S&P Global's (NYSE:SPGI) third quarter 2025 results will be issued on Thursday, October 30, 2025 via news release at approximately 7:15 a.m. Eastern Daylight Time. The news release will be available at www.spglobal.com. Martina Cheung, President and CEO; Eric Aboaf, Chief Financial Officer; and Mark Grant, Senior Vice President, Investor Relations and Treasurer, will host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on October 30, 2025 to discuss the Company's third quarter 2025 financial results. The presentation is open to all interested parties and may include forward-looking information. The presenters' slides, supplemental deck

    10/2/25 4:00:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    S&P Dow Jones Indices Announces Leadership Succession

    Catherine Clay Appointed CEO of S&P Dow Jones IndicesDan Draper to step down and will remain as a Special Advisor for a period of time after November 1, 2025NEW YORK, Oct. 2, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI"), the world's leading index provider, has appointed Catherine Clay as CEO, effective November 1, 2025. She will replace Dan Draper, who will remain as a Special Advisor for a period of time after November 1, 2025.  Ms. Clay will also replace Mr. Draper on the S&P Dow Jones Indices Board. Ms. Clay will report to Martina Cheung, President and CEO of S&P

    10/2/25 7:25:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    S&P Global Announces Updates to the Executive Leadership Team

    Catherine Clay appointed CEO of S&P Dow Jones Indices, effective November 1, 2025, replacing Dan DraperSwamy Kocherlakota, Chief Digital Solutions Officer, to also leave S&P GlobalMr. Draper and Mr. Kocherlakota will each remain with S&P Global through a transition period.NEW YORK, Oct. 2, 2025 /PRNewswire/ -- S&P Global (NYSE:SPGI) today announced updates to the Executive Leadership Team as part of the company's ongoing evolution to support its strategic priorities and continued growth. Catherine Clay has been appointed CEO of S&P Dow Jones Indices ("S&P DJI"), the world's le

    10/2/25 7:20:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $PGTI
    $ROIV
    $RUN
    $SPGI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Gline Matthew bought $49,957 worth of shares (3,315 units at $15.07), increasing direct ownership by 0.02% to 17,287,081 units (SEC Form 4)

    4 - Roivant Sciences Ltd. (0001635088) (Issuer)

    9/18/25 7:28:11 PM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fenster Edward Harris bought $543,500 worth of shares (50,000 units at $10.87), increasing direct ownership by 4% to 1,408,182 units (SEC Form 4)

    4 - Sunrun Inc. (0001469367) (Issuer)

    5/13/25 7:57:16 AM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    Director Fenster Edward Harris was granted 5,405 shares and bought $1,020,600 worth of shares (150,000 units at $6.80), increasing direct ownership by 13% to 1,358,182 units (SEC Form 4)

    4 - Sunrun Inc. (0001469367) (Issuer)

    3/3/25 9:16:18 PM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    $PGTI
    $ROIV
    $RUN
    $SPGI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Seaport Research Partners initiated coverage on S&P Global with a new price target

    Seaport Research Partners initiated coverage of S&P Global with a rating of Buy and set a new price target of $540.00

    10/1/25 9:39:03 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Sunrun upgraded by Jefferies with a new price target

    Jefferies upgraded Sunrun from Hold to Buy and set a new price target of $21.00

    10/1/25 9:23:43 AM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    Citigroup initiated coverage on Roivant Sciences with a new price target

    Citigroup initiated coverage of Roivant Sciences with a rating of Buy and set a new price target of $16.00

    9/2/25 8:40:38 AM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PGTI
    $ROIV
    $RUN
    $SPGI
    SEC Filings

    View All

    SEC Form 144 filed by Sunrun Inc.

    144 - Sunrun Inc. (0001469367) (Subject)

    10/1/25 5:17:12 PM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    Roivant Sciences Ltd. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Roivant Sciences Ltd. (0001635088) (Filer)

    9/17/25 7:45:44 AM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Roivant Sciences Ltd. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Roivant Sciences Ltd. (0001635088) (Filer)

    9/11/25 5:00:42 PM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PGTI
    $ROIV
    $RUN
    $SPGI
    Leadership Updates

    Live Leadership Updates

    View All

    Bentley Systems Set to Join S&P MidCap 400 and Western Union to Join S&P SmallCap 600

    NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Bentley Systems Inc. (NASD: BSY) will replace Western Union Co. (NYSE:WU) in the S&P MidCap 400, and Western Union will replace Mr. Cooper Group Inc. (NASD: COOP) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 6. Rocket Companies Inc. (NYSE:RKT) acquired Mr. Cooper Group in a deal that closed today, October 1. Western Union's market capitalization is more representative of the small-cap market space. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name        Action Company Name Ticker GICS Sector October 6, 2025   S&P MidCap

    10/1/25 6:03:00 PM ET
    $BSY
    $RKT
    $SPGI
    Computer Software: Prepackaged Software
    Technology
    Finance: Consumer Services
    Finance

    Carbon Data Open Protocol (CDOP) Coalition Unveils Open-Source Data Model at Climate Week NYC to Facilitate and Scale Carbon Markets

    37 organizations including Isometric, Verra, South Pole, and Kita commit to continue supporting the adoption and development of the Carbon Data Open Protocol (CDOP) Version 1.0 Open-source data schema for project location, details & approach addresses carbon market fragmentationDeveloped in alignment with, and building upon, other data standardization initiatives, including the G20-led Common Carbon Credit Data Model (CCCDM), the CAD Trust, and the UNFCCC (relating to Article 6)NEW YORK, Sept. 23, 2025 /PRNewswire/ -- Today at Climate Week NYC a growing coalition of carbon market participants announced the release of Version 1.0 of the Carbon Data Open Protocol (CDOP) structure to help facil

    9/23/25 7:00:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    ACM Research Set to Join S&P SmallCap 600

    NEW YORK, Sept. 22, 2025 /PRNewswire/ -- ACM Research Inc. (NASD: ACMR) will replace WK Kellogg Co. (NYSE:KLG) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, September 26. The Ferrero Group is acquiring WK Kellogg in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Sept 26, 2025 S&P SmallCap 600 Addition ACM Research ACMR Information Technology Sept 26, 2025 S&P SmallCap 600 Deletion WK Kellogg KLG Consumer Staples ABOUT S&P DOW JONES INDICES S&P Dow Jones Indices i

    9/22/25 6:16:00 PM ET
    $ACMR
    $KLG
    $SPGI
    Industrial Machinery/Components
    Technology
    Packaged Foods
    Consumer Staples

    $PGTI
    $ROIV
    $RUN
    $SPGI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Roivant Sciences Ltd.

    SC 13G/A - Roivant Sciences Ltd. (0001635088) (Subject)

    11/14/24 4:31:06 PM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Sunrun Inc.

    SC 13G/A - Sunrun Inc. (0001469367) (Subject)

    11/14/24 2:08:47 PM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Sunrun Inc.

    SC 13G/A - Sunrun Inc. (0001469367) (Subject)

    11/13/24 6:57:07 AM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    $PGTI
    $ROIV
    $RUN
    $SPGI
    Financials

    Live finance-specific insights

    View All

    S&P Global Schedules Third Quarter 2025 Earnings Announcement and Conference Call for Thursday, October 30, 2025

    NEW YORK, Oct. 2, 2025 /PRNewswire/ -- S&P Global's (NYSE:SPGI) third quarter 2025 results will be issued on Thursday, October 30, 2025 via news release at approximately 7:15 a.m. Eastern Daylight Time. The news release will be available at www.spglobal.com. Martina Cheung, President and CEO; Eric Aboaf, Chief Financial Officer; and Mark Grant, Senior Vice President, Investor Relations and Treasurer, will host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on October 30, 2025 to discuss the Company's third quarter 2025 financial results. The presentation is open to all interested parties and may include forward-looking information. The presenters' slides, supplemental deck

    10/2/25 4:00:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    S&P 500 Q2 2025 Buybacks Declines 20% Amidst Uncertainty to $235 Billion From Q1 2025's Record $293 Billion; Q3 2025 Expenditures Expected to Increase Back to Near Record Levels

    S&P 500 Q2 2025 buybacks were $234.6 billion, as the expenditure declined 20.1% from the record Q1 2025 $293.5 billion and was down 0.6% from Q2 2024's $235.9 billionThe 12-month June 2025 expenditure was $997.8 billion and was up 13.7% from the 12-month June 2024 expenditure of $877.5 billion Utilities was the only sector to increase spending, up 16.5% over Q1 2025, Health Care reduced spending by 39.3%, Information Technology by 16.3% and Communication Services by 15.0%The net buyback 1% tax reduced Q2 2025 operating earnings, which are set to post a quarterly earnings record, by 0.39% and As Reported GAAP by 0.42%, as the 12-month cost was 0.42% and 0.45%, respectivelyNEW YORK, Sept. 17,

    9/17/25 9:00:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Roivant and Priovant Announce Positive Phase 3 VALOR Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (DM)

    Once-daily oral brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared to placebo on the primary endpoint and all nine key secondary endpoints, including measurements of skin disease, muscle disease, steroid-sparing effect, and rapidity of onsetOn the primary endpoint, brepocitinib 30 mg achieved a week 52 mean Total Improvement Score (TIS) of 46.5 compared to 31.2 for placebo (p=0.0006​), even with nearly twice as many patients coming off background steroids on brepocitinib 30 mg compared to placeboMore than two thirds of brepocitinib 30 mg patients experienced at least a moderate response (TIS≥40), and nearly half experienced a major respon

    9/17/25 7:00:00 AM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care